Abbott Reports 14.5% Sales Growth in Q3 2026 and Reaffirms Guidance

Key Facts

1Abbott reported third-quarter sales growth of 14.5 percent.

2Adjusted diluted EPS reached $1.42 for the third quarter with reaffirmed full-year guidance.

Abbott reported third-quarter sales growth of 14.5 percent for 2026. According to a statement on PR Newswire, adjusted diluted EPS reached $1.42 for the quarter, and the company reaffirmed its full-year guidance.

ABT closed at $102.45 on October 20, 2026, prior to the results which showed a 7.0 percent increase in comparable sales. The performance reflects portfolio expansion driven by new product approvals during the third quarter.